Search - tctmd.com

Displaying 261 - 280 of 392

Sort: Relevancy | Date

News Daily News

Year in Review: Physicians Highlight the Most Important Interventional News of 2012

Caitlin E. Cox

January 02, 2013

News Daily News

‘Top Ten’ Advances of 2012 Highlighted by AHA-ASA, ACC

Caitlin E. Cox

December 26, 2012

News Daily News

SCAI Updates Recommendations for Ad Hoc PCI

Yael L. Maxwell

December 02, 2012

News Daily News

Meta-analysis Questions Benefit of Longer Dual Antiplatelet Therapy Post-PCI

November 28, 2012

News Conference News AHA 2012

OLIVE: Endovascular Treatment Shows Positive Results for Critical Limb Ischemia

Jason Kahn

November 06, 2012

News Conference News AHA 2012

TRILOGY ACS Substudy: No Relationship Between Platelet Reactivity, Outcomes

November 04, 2012

News Industry News

Boston Scientific Receives CE Mark Approval for the SYNERGY™ Everolimus-Eluting Platinum Chromium Coronary Stent System, Featuring A Novel Bioabsorbable Polymer Coating

October 31, 2012

News Conference News TCT 2012

PARTNER: Benefits of TAVR Sustained Out to 3 Years

October 25, 2012

News Conference News TCT 2012

Experts Discuss Future of Renal Denervation

October 25, 2012

News Industry News

Clinical Trial Suggests PFO Closure with Investigational Device is Safe and May Improve Clinical Outcomes Compared to Medical Management in the Prevention of Cryptogenic Stroke

October 25, 2012

News Industry News

8500+ Patient Trial Validates Association between High Platelet Reactivity and 1-Year Cardiovascular Outcomes at TCT 2012

October 25, 2012

News Industry News

Study Finds That Prasugrel May Reduce Cardiovascular Events Among Patients Managed Medically After an Angiogram for Acute Coronary Syndrome

October 24, 2012

News Industry News

PROMUS Element™ and PROMUS Element™ Plus Receive CE Mark Approval for Labeling Update to Include Three-Month Dual Anti-Platelet Therapy

October 24, 2012

News Conference News TCT 2012

Paradigm Shift from Ischemia to Vulnerable Plaque Needed to Prevent Sudden Coronary Death

October 24, 2012

News Industry News

FFR-Guided PCI Demonstrates Cost-Effectiveness When Compared to Medical Therapy for Stable Coronary Artery Disease

October 24, 2012

News Daily News

SCAI Survey, Consensus Statement Draw Attention to Quality of Life

Caitlin E. Cox

October 23, 2012

News Conference News TCT 2012

COURAGE, FAME: Revascularization More Effective Than OMT

October 22, 2012

News Daily News

New Class of Oral Anticoagulants Safer Compared with Warfarin for A-fib

October 19, 2012

News Daily News

Revascularization After CTA Confers Mortality Benefit in Stable Patients at High Risk

L.A. McKeown

October 15, 2012

News Daily News

Almost 1 in 10 STEMIs Caused by Stent Thrombosis

October 12, 2012

Advertisement

Year in Review: Physicians Highlight the Most Important Interventional News of 2012

‘Top Ten’ Advances of 2012 Highlighted by AHA-ASA, ACC

SCAI Updates Recommendations for Ad Hoc PCI

Meta-analysis Questions Benefit of Longer Dual Antiplatelet Therapy Post-PCI

OLIVE: Endovascular Treatment Shows Positive Results for Critical Limb Ischemia

TRILOGY ACS Substudy: No Relationship Between Platelet Reactivity, Outcomes

Boston Scientific Receives CE Mark Approval for the SYNERGY™ Everolimus-Eluting Platinum Chromium Coronary Stent System, Featuring A Novel Bioabsorbable Polymer Coating

PARTNER: Benefits of TAVR Sustained Out to 3 Years

Experts Discuss Future of Renal Denervation

Clinical Trial Suggests PFO Closure with Investigational Device is Safe and May Improve Clinical Outcomes Compared to Medical Management in the Prevention of Cryptogenic Stroke

8500+ Patient Trial Validates Association between High Platelet Reactivity and 1-Year Cardiovascular Outcomes at TCT 2012

Study Finds That Prasugrel May Reduce Cardiovascular Events Among Patients Managed Medically After an Angiogram for Acute Coronary Syndrome

PROMUS Element™ and PROMUS Element™ Plus Receive CE Mark Approval for Labeling Update to Include Three-Month Dual Anti-Platelet Therapy

Paradigm Shift from Ischemia to Vulnerable Plaque Needed to Prevent Sudden Coronary Death

FFR-Guided PCI Demonstrates Cost-Effectiveness When Compared to Medical Therapy for Stable Coronary Artery Disease

SCAI Survey, Consensus Statement Draw Attention to Quality of Life

COURAGE, FAME: Revascularization More Effective Than OMT

New Class of Oral Anticoagulants Safer Compared with Warfarin for A-fib

Revascularization After CTA Confers Mortality Benefit in Stable Patients at High Risk

Almost 1 in 10 STEMIs Caused by Stent Thrombosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content